GOLDMAN SACHS GROUP INC - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 152 filers reported holding ARCUS BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 3.92 and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$10,558,334
-13.1%
588,208
-1.7%
0.00%0.0%
Q2 2023$12,148,122
-17.2%
598,135
-25.7%
0.00%
-33.3%
Q1 2023$14,674,700
-6.9%
804,534
+5.5%
0.00%
-25.0%
Q4 2022$15,766,846
-30.2%
762,420
-11.7%
0.00%
-20.0%
Q3 2022$22,586,000
-8.5%
863,385
-11.4%
0.01%
-16.7%
Q2 2022$24,685,000
+217.4%
974,132
+295.3%
0.01%
+200.0%
Q1 2022$7,777,000
+70.9%
246,440
+119.1%
0.00%
+100.0%
Q4 2021$4,551,000
+121.7%
112,461
+91.1%
0.00%
Q3 2021$2,053,000
-82.1%
58,852
-85.9%
0.00%
-100.0%
Q2 2021$11,444,000
-29.9%
416,731
-28.3%
0.00%
-25.0%
Q1 2021$16,327,000
-17.2%
581,451
-23.4%
0.00%
-20.0%
Q4 2020$19,708,000
+152.9%
759,163
+67.0%
0.01%
+150.0%
Q3 2020$7,793,000
-42.8%
454,668
-17.4%
0.00%
-50.0%
Q2 2020$13,616,000
+1076.8%
550,367
+560.3%
0.00%
Q1 2020$1,157,000
-6.5%
83,356
-31.9%
0.00%
Q4 2019$1,237,000
+45.5%
122,435
+31.0%
0.00%
Q3 2019$850,000
+15.3%
93,453
+0.8%
0.00%
Q2 2019$737,000
+33.8%
92,715
+110.0%
0.00%
Q1 2019$551,000
+27.5%
44,152
+10.2%
0.00%
Q4 2018$432,000
+70.1%
40,078
+120.0%
0.00%
Q3 2018$254,000
-28.0%
18,215
-36.9%
0.00%
Q2 2018$353,000
-82.3%
28,853
-77.6%
0.00%
-100.0%
Q1 2018$1,992,000129,0250.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q1 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$65,241,00019.83%
Octagon Capital Advisors LP 2,095,231$84,794,00016.50%
EcoR1 Capital, LLC 5,523,358$223,530,0007.12%
BVF INC/IL 3,398,067$137,520,0004.99%
PFM Health Sciences, LP 3,431,010$138,853,0004.73%
Alphabet Inc. 2,563,441$103,742,0002.50%
Boxer Capital, LLC 1,432,200$57,961,0002.25%
PARK CIRCLE Co 64,000$2,590,0002.04%
SECTORAL ASSET MANAGEMENT INC 283,210$11,462,0001.72%
DAFNA Capital Management LLC 117,200$4,743,0001.19%
View complete list of ARCUS BIOSCIENCES INC shareholders